These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 9594623
1. [GAD antibody in IDDM]. Yokota I, Shima K. Rinsho Byori; 1998 Apr; 46(4):331-7. PubMed ID: 9594623 [Abstract] [Full Text] [Related]
3. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Thai AC, Ng WY, Loke KY, Lee WR, Lui KF, Cheah JS. Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950 [Abstract] [Full Text] [Related]
4. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Yano M, Moriuchi R, Kawasaki E, Watanabe M, Saito K, Takino H, Akazawa S, Miyamoto T, Nagataki S. J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039 [Abstract] [Full Text] [Related]
5. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? Schmidli RS, Colman PG, Harrison LC. J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043 [Abstract] [Full Text] [Related]
6. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W. J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [Abstract] [Full Text] [Related]
7. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Nature; 1990 Sep 13; 347(6289):151-6. PubMed ID: 1697648 [Abstract] [Full Text] [Related]
8. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG. J Autoimmun; 1994 Feb 13; 7(1):55-66. PubMed ID: 8198702 [Abstract] [Full Text] [Related]
9. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives]. Kretowski A, Kowalska I, Peczyńska J, Urban M, Kinalska I. Przegl Lek; 2000 Feb 13; 57(3):143-6. PubMed ID: 10909282 [Abstract] [Full Text] [Related]
10. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. Sera Y, Kawasaki E, Abiru N, Ozaki M, Abe T, Takino H, Kondo H, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S, Uchigata Y, Matsuura N, Eguchi K. J Autoimmun; 1999 Sep 13; 13(2):257-65. PubMed ID: 10479394 [Abstract] [Full Text] [Related]
11. [Islet cell antibodies]. Hanafusa T. Rinsho Byori; 1995 May 13; 43(5):460-2. PubMed ID: 7783363 [Abstract] [Full Text] [Related]
12. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ. Pediatr Diabetes; 2005 Dec 13; 6(4):184-92. PubMed ID: 16390386 [Abstract] [Full Text] [Related]
13. [Islet autoantibody assays in type I diabetes: superiority of passage from use of ICA to traditional tests]. Lazar D, Weintrob N, Abramov N, Assa S, Bloch K, Ofan R, Ben-Zaken H, Vardi P. Harefuah; 1998 May 01; 134(9):678-81, 750. PubMed ID: 10909610 [Abstract] [Full Text] [Related]
14. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Franke B, Galloway TS, Wilkin TJ. Diabetes Metab Res Rev; 2005 May 01; 21(5):395-415. PubMed ID: 15895384 [Abstract] [Full Text] [Related]
15. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. J Clin Invest; 1992 Jan 01; 89(1):283-92. PubMed ID: 1370298 [Abstract] [Full Text] [Related]
16. Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice. Kash SF, Condie BG, Baekkeskov S. Horm Metab Res; 1999 May 01; 31(5):340-4. PubMed ID: 10422732 [Abstract] [Full Text] [Related]
17. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. Hou J, Sheikh S, Martin DL, Chatterjee NK. J Autoimmun; 1993 Oct 01; 6(5):529-42. PubMed ID: 8240659 [Abstract] [Full Text] [Related]
18. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF. J Autoimmun; 1998 Dec 01; 11(6):643-50. PubMed ID: 9878086 [Abstract] [Full Text] [Related]
19. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes. Desailloud R, Fajardy I, Vambergue A, Prevost G, Pigny P, Fontaine P. Diabetes Metab; 2000 Nov 01; 26(5):353-60. PubMed ID: 11119014 [Abstract] [Full Text] [Related]
20. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes. Hamaguchi K, Kimura A, Kusuda Y, Yamashita T, Yasunami M, Takahasi M, Abe N, Yoshimatsu H. Diabetes Res Clin Pract; 2004 Nov 01; 66(2):163-71. PubMed ID: 15533584 [Abstract] [Full Text] [Related] Page: [Next] [New Search]